On the basis of these results, we used MSCs as tumoral promoters by co-injecting them in mice together with melanoma cells, with the aim of enriching tumor microenvironment with SDF-1 molecular magnets able to recruit ECFC-MMP12. This evidence concerns the gene MMP12 and melanoma.